Brand Name | Status | Last Update |
---|---|---|
fluorodopa | New Drug Application | 2021-01-15 |
Expiration | Code | ||
---|---|---|---|
FLUORODOPA F-18, FLUORODOPA F18, FEINSTEIN | |||
2024-10-10 | NCE, W |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | — | — | — | — | 1 |
Squamous cell carcinoma | D002294 | — | — | 1 | — | — | — | — | 1 |
Mouth neoplasms | D009062 | EFO_0003868 | C06.9 | 1 | — | — | — | — | 1 |
Fibrosis | D005355 | — | — | 1 | — | — | — | — | 1 |
Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | 1 | — | — | — | — | 1 |
Pulmonary fibrosis | D011658 | — | J84.10 | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | — | — | — | — | 2 | 2 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | — | 1 | 1 |
Esophageal neoplasms | D004938 | — | C15 | — | — | — | — | 1 | 1 |
Adenocarcinoma | D000230 | — | — | — | — | — | — | 1 | 1 |
Esophageal squamous cell carcinoma | D000077277 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Fluorodopa f 18 |
INN | fluorodopa (18f) |
Description | 6-((18)F)fluoro-L-dopa is a 6-fluoro-L-dopa and a (18)F radiopharmaceutical. |
Classification | Small molecule |
Drug class | dopamine receptor agonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N[C@@H](Cc1cc(O)c(O)cc1[18F])C(=O)O |
PDB | — |
CAS-ID | 92812-82-3 |
RxCUI | — |
ChEMBL ID | CHEMBL3400972 |
ChEBI ID | 49166 |
PubChem CID | 56494 |
DrugBank | DB13848 |
UNII ID | 2C598205QX (ChemIDplus, GSRS) |